Evidence map›Paper›PMID 34684896›Full record

ReviewMolecules (Basel, Switzerland)2021

The Application of Chitosan Nanostructures in Stomatology.

Shunli Chu, Jue Wang, Fengxiang Gao

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in dental medicine · 2025
    Article
  4. Review
  5. Review
  6. [Comparison of a new thermosensitive rhAm carrier versus traditional PGA carrier forNan fang yi ke da xue xue bao = Journal of Southern Medical University · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shunli ChuDepartment of Implantology, Hospital of Stomatology, Jilin University, Changchun 130000, China.ORCID 0000-0002-5074-6340
Jue WangDepartment of Prosthodontics, Hospital of Stomatology, Jilin University, Changchun 130000, China.
Fengxiang GaoChangchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130000, China.
Jilin University · CNChinese Academy of Sciences · CN

Funding

Financial support from the Projects directly under Jilin Provincial Department of Finance, China JCSZ2019378-23Scientific Research Project of Jilin Provincial Department of Education, China JJKH20211215KJ
6 · The paper itself

Abstract

Chitosan (CS) is a natural polymer with a positive charge, a deacetylated derivative of chitin. Chitosan nanostructures (nano-CS) have received increasing interest due to their potential applications and remarkable properties. They offer advantages in stomatology due to their excellent biocompatibility, their antibacterial properties, and their biodegradability. Nano-CSs can be applied as drug carriers for soft tissue diseases, bone tissue engineering and dental hard tissue remineralization; furthermore, they have been used in endodontics due to their antibacterial properties; and, finally, nano-CS can improve the adhesion and mechanical properties of dental-restorative materials due to their physical blend and chemical combinations. In this review, recent developments in the application of nano-CS for stomatology are summarized, with an emphasis on nano-CS's performance characteristics in different application fields. Moreover, the challenges posed by and the future trends in its application are assessed.

Indexed as

AnimalsBiocompatible MaterialsChitinChitosanHumansNanostructuresPolymersTissue EngineeringTissue ScaffoldsBiocompatible MaterialsChitinChitosanPolymersdrug carrynano-chitosanremineralizationroot canal treatmenttissue engineering

Identifiers

PMID34684896
PMCPMC8541323
OpenAlexW3205002355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.